BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Galmed Pharmaceuticals Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:03 pm Sale | 2022-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | BIOTECHNOLOGY VALUE FUND L P | 9,665 6.900% | -333 (-3.34%) | Filing |
| 2021-02-12 4:13 pm Sale | 2020-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD | BIOTECHNOLOGY VALUE FUND L P | 9,998 8.400% | -182 (-1.79%) | Filing |